Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Vaccines01:30

Cancer Vaccines

329
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TOPO-seq reveals DNA topology-induced off-target activity by Cas9 and base editors.

Nature chemical biology·2025
Same author

Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia.

Cell stem cell·2024
Same author

Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs.

Cell stem cell·2023
Same author

Current advances of CRISPR-Cas technology in cell therapy.

Cell insight·2023
Same author

Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.

International journal of medical sciences·2021
Same author

An improved method validation for rapid determination of acrylamide in foods by ultra-performance liquid chromatography combined with tandem mass spectrometry.

Journal of chromatography. A·2007

Related Experiment Video

Updated: May 29, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

14.9K

Precision epitope editing: A path to advanced immunotherapies.

Rui-Jin Ji1, Mu-Yao Wang1, Ying Zhang1,2,3,4

  • 1Esophagus, Mediastinum and Lymphatic Oncology Department, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, Hubei, China.

Cell Insight
|February 5, 2025
PubMed
Summary

Engineering antigen epitopes on hematopoietic stem and progenitor cells (HSPCs) protects them from targeted immunotherapy toxicity. This preserves cell function, enhancing cancer treatment safety and effectiveness.

Keywords:
AMLCRISPREpitopeHSPCPrecision editingPrime editing

More Related Videos

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
08:04

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

6.8K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.2K

Related Experiment Videos

Last Updated: May 29, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

14.9K
Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
08:04

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

6.8K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.2K

Area of Science:

  • Immunology and Cancer Therapy
  • Gene Editing Technologies

Background:

  • Antigen epitope recognition is vital for immune responses.
  • Targeted immunotherapies face challenges with on-target/off-tumor toxicity.
  • Hematopoietic stem and progenitor cells (HSPCs) are susceptible to immunotherapy damage.

Purpose of the Study:

  • To investigate methods for protecting healthy HSPCs during tumor immunotherapy.
  • To explore the potential of engineering epitopes on HSPCs to enhance treatment safety.

Main Methods:

  • Utilizing gene editing tools to modify epitopes on HSPCs.
  • Assessing the protective effects of engineered epitopes against immunotherapy-induced toxicity.
  • Evaluating the differentiation and functional capacity of modified HSPCs.

Main Results:

  • Engineered epitopes on HSPCs confer protection against targeted immunotherapy.
  • Modified HSPCs maintain their normal differentiation and function post-treatment.
  • Gene editing strategies successfully reduced off-tumor toxicity.

Conclusions:

  • Engineering epitopes on HSPCs is a promising strategy to improve targeted immunotherapy safety.
  • This approach allows for effective tumor eradication while preserving essential stem cell functions.
  • Further development in gene editing can enhance the efficacy and tolerability of cancer treatments.